Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.
about
Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entryDivergent susceptibilities of human herpesvirus 6 variants to type I interferonsCo-infections and Pathogenesis of KSHV-Associated MalignanciesHuman Herpesvirus-6 Encephalitis After Hematopoietic Stem Cell TransplantationAntiviral T-cell therapyGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveHHV-6 reactivation and associated sequelae after hematopoietic cell transplantationHHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipientsFrequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Cytotoxic T lymphocytes as immune-therapy in haematological practice.Detection of adeno-associated virus viremia in hematopoietic cell transplant recipients.Simultaneous human herpesvirus 6-associated encephalitis and Guillain-Barré syndrome in a patient after matched unrelated donor haematopoietic stem cell transplantationHuman Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD.Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris.Characterization of human herpesvirus 6A/B U94 as ATPase, helicase, exonuclease and DNA-binding proteins.Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation.Lymphotropic herpesvirus DNA detection in patients with active CMV infection - a possible role in the course of CMV infection after hematopoietic stem cell transplantation.Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantationPrevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience.Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.Central nervous system infections in immunocompromised patients: update on diagnostics and therapy.Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cellsChallenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.New aspects of drug-induced hypersensitivity syndrome.Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis.Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials.Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.Inhibition of interleukin-2 gene expression by human herpesvirus 6B U54 tegument proteinChromosomally Integrated Human Herpesvirus 6: Models of Viral Genome Release from the Telomere and Impacts on Human Health.Transmission of chromosomally integrated human herpesvirus 6 via cord blood transplantation.Absence of human herpesvirus 6B detection in association with illness in children undergoing cancer chemotherapy.Analysis of human herpes virus 6 infections with a quantitative, standardized, commercial kit in pediatric stem cell transplant recipients after transplantation.Cycling probe-based real-time PCR for the detection of Human herpesvirus 6A and B.Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.Fatal Myocarditis Associated With HHV-6 Following Immunosuppression in Two ChildrenClostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation.
P2860
Q24631036-BCF1C838-C495-4486-900A-4F7603DC38AFQ24631220-033CEA78-90A7-4EA7-B616-94CB86C0EEEBQ26766493-EF843B0A-B07C-41FB-92AD-16DA5FFC8357Q27010284-668E1EB8-8A4E-480B-8B1F-639CB99DC401Q27028006-584C82B5-84EA-470F-A68F-6BAE0792CF34Q28388806-9227BC6F-097C-42E7-AC89-DD14A08E848CQ28727925-F0ACC304-89EE-4EDB-8DAC-CF46A43D1FE2Q28743914-0B5167DA-3667-42AF-9AD3-FCCB45AF8677Q33897804-4B1AA16C-6A41-4C93-898A-D264BE8FE821Q34273968-A5232176-8135-488B-A214-A6848DB6D20FQ35157540-044A451A-3C19-4A77-94EA-60B0F0813A70Q35463834-04226004-1BFA-47F8-B9C6-87BA86072A1EQ35762061-362151BC-01C4-4084-B7B1-6131EF009231Q35764761-4B610075-1317-41C5-9250-99BDF2C29C4EQ35774717-D3078176-A385-4DDB-879A-E61ACA239186Q35818622-0D95C175-1706-46E3-AA51-62E796EF6297Q35842494-D0A5E32D-5862-40E2-B48D-1936488C24B7Q35849274-96276D11-DB92-4CAC-B065-2BE21C1FC51AQ36516712-614B205E-FC1C-4DE9-8E3D-D6ADAF0286A0Q37006823-EBC1355E-B90B-4810-9E5B-F39018763D3AQ37177116-A5FA2908-85AA-4285-A0B3-34B9D5D0020AQ37276889-5D7EE62B-D8F6-4353-9D18-1D87C11F25B4Q37334159-04802C62-E360-4F6C-86CB-A0C7C6035119Q37561897-4C92A5DD-9881-4222-AA07-4B0D0CEEC1A8Q37687412-C5AFA1F7-8D0C-49F3-A61A-32E4B2D71AAFQ37845909-C8926467-3A8B-430E-9D19-95ACF6A86107Q38002109-9A955E22-6FF8-434F-8DFB-E5509E409909Q38045704-2D34236C-AE29-4493-B694-AA017A111C64Q38256992-F6FC0DCC-7BF2-4673-92C5-1135975EE0B9Q38444117-27077577-8F3B-4464-BEB9-5FEE78F090F9Q38637173-ACD1AF17-4F71-4C59-96CF-6031A996755AQ38966105-0C76C070-F0BA-4B2C-9153-18C330DBA9E8Q39433139-B90CD7DC-13D4-4F3F-8423-546F0C82789DQ40079621-A6B0EC39-6A0B-4B66-9A11-2A42C54637AAQ40120756-80623C2F-2B7E-4717-AB53-B2FF4DD56F07Q40213229-BC1BCD71-F001-4227-A622-55AB416A6ED2Q40766749-E57FF471-1767-4757-B1B8-B8E74BCA6706Q40849677-112B3C0A-83B2-4A2F-B3B2-CBB51674F560Q40866127-62B66271-7296-430E-BB2D-EFF17C774F5BQ40870178-98B50419-3C61-4130-9614-D7E7AB2336C3
P2860
Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinical outcomes of human her ...... tic stem cell transplantation.
@ast
Clinical outcomes of human her ...... tic stem cell transplantation.
@en
type
label
Clinical outcomes of human her ...... tic stem cell transplantation.
@ast
Clinical outcomes of human her ...... tic stem cell transplantation.
@en
prefLabel
Clinical outcomes of human her ...... tic stem cell transplantation.
@ast
Clinical outcomes of human her ...... tic stem cell transplantation.
@en
P2093
P2860
P50
P356
P1476
Clinical outcomes of human her ...... tic stem cell transplantation.
@en
P2093
Danielle M Zerr
Hyung W Kim
P2860
P304
P356
10.1086/428060
P407
P577
2005-03-02T00:00:00Z